2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2024

2023

2022

Freesmeyer M, Drescher R, Kuhnel C, Guhne F, Greiser J. Hepatobiliary Excretion PET/CT With 68Ga-TAoS-DAZA to Evaluate Bile Duct Patency. Clinical nuclear medicine. 2022;47(1):59-60.

Winkens T, Christl A, Kuehnel C, Ndum F, Seifert P, Greiser J, Freesmeyer, M. In-ovo imaging using ostrich eggs-Evaluation of physiological embryonal development on computed tomography. Acta Zoologica. 2022;103(4):492-502.

Seifert P, Greiser J, Winkens T, Lorenz K, Freesmeyer M. Ectopic Retrolaryngeal Parathyroid Adenoma Detected by 18F-Ethylcholine PET/US Fusion Imaging. Clinical nuclear medicine. 2022;47(2):182-4.

Schroeter T, Guhne F, Schwab M, Drescher R, Axer H. Differentiation of Reversible Hemichorea Due to Vitamin B12 Deficiency From Huntington Disease Via FDG PET. Clinical nuclear medicine. 2022;47(9):830-1.

Schrenk KG, Weschenfelder W, Spiegel C, Agaimy A, Stohr R, Hartmann, Gassler N,
Drescher R, Freesmeyer M, Malouhi A, Burckenmeyer F, Aschenbach R, Teichgraber U, Kogler C, Vogt M, Hofmann GO, Hochhaus A. Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcoma. J Cancer Res Clin Oncol. 2022.

Rinscheid A, Janzen T, Alikhani B, Beer AJ, Braune A, Eberhardt N, Fechner D, Forster S, Freesmeyer M, Furth C, Grunert M, Hellwig D, Costa PF, Kuhnel C, Lange C, Linke R, Razlaw N, Sack T, Schmidt D, Schutze C, Starke A, Tondera L, Wengenmair H, Zophel K, Burchert W, Lapa C. Radiation doses from low-dose CT scans in SPECT/CT and PET/CT examinations: A survey in Germany. Nuklearmedizin. 2022;61(4):294-300.

Pfeil A, Hoffmann T, Freesmeyer M, Wolf G, Oelzner P. Entzündlich-rheumatische Erkrankungsbilder der Schulter. Thüringer Ärzteblatt. 2022(2):10-2.

Malich L, Guhne F, Hoffmann T, Malich A, Weise T, Oelzner P, Wolf G, Freesmeyer M, Pfeil A. Distribution patterns of arterial affection and the influence of glucocorticoids on (18)F-fluorodeoxyglucose positron emission tomography/CT in patients with giant cell arteritis. RMD Open. 2022;8(2).

Leder T, Seifert P, Drescher R, Guhne F, Freesmeyer M. Excellent Response to Multimodal Therapy Approach in Hyperfunctioning Metastatic Follicular Thyroid Carcinoma Diagnosed on 123I-SPECT/Ultrasound Fusion Imaging. Clinical nuclear medicine. 2022.

Leder T, Drescher R, Guhne F, Theis B, Freesmeyer M. De Quervain Subacute Thyroiditis With Moderate PSMA Uptake Mimicking Thyroid Metastasis of Renal Cell Carcinoma. Clinical nuclear medicine. 2022;47(3):221-2.

Kühnel C, Gühne F, Seifert P, Freudenberg R, Freesmeyer M, Drescher R. Transarterial Radioembolization Planning and Treatment with Microspheres Containing Holmium-166: Determination of Renal and Intestinal Radionuclide Elimination, Effective Half-life, and Regulatory Aspects. 2022.

Greiser J, Winkens T, Perkas O, Kuehnel C, Weigand W, Freesmeyer M. Automated GMP Production and Preclinical Evaluation of [68Ga]Ga-TEoS-DAZA and [68Ga]Ga-TMoS-DAZA. Pharmaceutics. 2022;14(12).

Freesmeyer M, Muller UA, Mannel M, Mtuka-Pardon G, Seifert P. Synchronous Metastatic Medullary Thyroid Carcinoma and Paraesophageal Parathyroid Adenoma Detected on 18 F-Ethylcholine PET/US Fusion Imaging. Clinical nuclear medicine. 2022;47(11):977-9.

Freesmeyer M, Hermeyer H, Kuehnel C, Perkas O, Greiser J, Witte OW, Winkens T. In-ovo imaging using ostrich eggs: Biomagnetism for detection of cardiac signals and embryonal motion. Exp Biol Med (Maywood). 2022;247(12):996-1004.

Freesmeyer M, Guhne F, Drescher R, Winkens T, Gassler N, Seifert P. Multimodal Characterization of a PSMA-Positive Thyroid Nodule Using (68)Ga-PSMA and (124)Iodine PET/US Fusion Imaging. Diagnostics (Basel). 2022;12(2).

Freesmeyer M, Greiser J, Grober S, Drescher R. Re: Multimodality imaging of developmental splenic anomalies: tips and pitfalls. Clin Radiol. 2022;77(5):326-7.

Freesmeyer M, Drescher R, Kuhnel C, Guhne F, Greiser J. Hepatobiliary Excretion PET/CT With 68Ga-TAoS-DAZA to Evaluate Bile Duct Patency. Clinical nuclear medicine. 2022;47(1):59-60.

2021

Drescher R, Grober S, Seifert P, Freesmeyer M. Differentiation of residual splenic tissue from neuroendocrine tumor metastasis on PET/CT with heat-damaged, Ga-68-oxine-labeled red blood cells. Jpn J Clin Oncol. 2021;51(1):160-1.

Drescher R, Seifert P, Guhne F, Aschenbach R, Kuhnel C, Freesmeyer M. Radioembolization With Holmium-166 Polylactic Acid Microspheres: Distribution of Residual Activity in the Delivery Set and Outflow Dynamics During Planning and Treatment Procedures. J Endovasc Ther. 2021;28(3):452-62.

Eisfeld H, Kircher S, Rosenwald A, Anagnostopoulos I, Werner M, Gassler N, Wolf G, Lehmkuhl L, Teichgraber U, Guhne F, Darr A, Freesmeyer M, Weschenfelder W, Hofmann G, Dalkilic R, Kalff R, Hochhaus A, Schrenk KG. Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL). Ann Hematol. 2021;100(4):1107-9.

Freesmeyer M, Greiser J, Winkens T, Guhne F, Kuhnel C, Rauchfuss F, Tautenhahn HM, Drescher R. Dynamic PET/CT with the Hepatobiliary Tracer [68Ga]Ga-Tmos-DAZA for Characterization of a Hepatic Tumor. Diagnostics (Basel). 2021;11(4).

Gühne F, Radke S, Winkens T, Kühnel C, Greiser J, Seifert P, Drescher R, Freesmeyer M. Differences in Distribution and Detection Rate of the [68Ga]Ga-PSMA Ligands PSMA-617, -I&T and -11—Inter-Individual Comparison in Patients with Biochemical Relapse of Prostate Cancer. Pharmaceuticals. 2021;15(1).

Guhne F, Seifert P, Theis B, Steinert M, Freesmeyer M, Drescher R. PSMA-PET/CT in Patients with Recurrent Clear Cell Renal Cell Carcinoma: Histopathological Correlations of Imaging Findings. Diagnostics (Basel). 2021;11(7).

Leder T, Drescher R, Guhne F, Theis B, Freesmeyer M. De Quervain Subacute Thyroiditis With Moderate PSMA Uptake Mimicking Thyroid Metastasis of Renal Cell Carcinoma. Clinical nuclear medicine. 2021.

Mentzel HJ, Freesmeyer M, Eckoldt-Wolke F, Vilser C. Phäochromozytom im Kindesalter – Contrast-enhanced Ultrasound (CEUS) als mögliche Alternative zur kontrastverstärkten MRT in der Diagnostik von Nebennierentumoren. Rofo. 2021;193(12):1467-9.

Schenke SA, Gorges R, Seifert P, Zimny M, Kreissl MC. Update on diagnosis and treatment of hyperthyroidism: ultrasonography and functional imaging. Q J Nucl Med Mol Imaging. 2021;65(2):102-12.

Seifert P, Greiser J, Winkens T, Lorenz K, Freesmeyer M. Ectopic Retrolaryngeal Parathyroid Adenoma Detected by 18F-Ethylcholine PET/US Fusion Imaging. Clinical nuclear medicine. 2021.

Seifert P, Schenke S, Zimny M, Stahl A, Grunert M, Klemenz B, Freesmeyer M, Kreissl MC, Herrmann K, Gorges R. Diagnostic Performance of Kwak, EU, ACR, and Korean TIRADS as Well as ATA Guidelines for the Ultrasound Risk Stratification of Non-Autonomously Functioning Thyroid Nodules in a Region with Long History of Iodine Deficiency: A German Multicenter Trial. Cancers (Basel). 2021;13(17).

Winkens T, Christl A, Kuehnel C, Ndum F, Seifert P, Greiser J, Freesmeyer M. In-ovo imaging using ostrich eggs-Evaluation of physiological embryonal development on computed tomography. Acta Zoologica. 2021.

Winkens T, Rudakoff W, Rauchfuss F, Malessa C, Settmacher U, Freesmeyer M. FDG PET/CT to Detect Incidental Findings in Patients With Hepatocellular Carcinoma-Additional Benefit for Patients Considered for Liver Transplantation? Clinical nuclear medicine. 2021;46(7):532-9.

Guhne F, Drescher R, Seifert P, Freesmeyer M. Supplemental minimal-activity PET/CT to validate ambiguous findings with less than 1 mSv: Proof of concept. J Med Imaging Radiat Oncol. 2021;65(2):201-7.

Seifert P, Maikowski I, Winkens T, Kuhnel C, Guhne F, Drescher R, Freesmeyer M. Ultrasound Cine Loop Standard Operating Procedure for Benign Thyroid Diseases-Evaluation of Non-Physician Application. Diagnostics (Basel). 2021;11(1).

Guntinas-Lichius O, Ihrler S, Freesmeyer M, Guhne F, Kluge R, Brauer L, Iro H, Paulsen F, Dietz A, Bechmann I. [Is there a new salivary gland? - Rather not!]. Laryngo- rhino- otologie. 2021;100(1):12-4.

Rekowski J, Huttmann A, Schmitz C, Muller SP, Kurch L, Kotzerke J, Franzius C, Weckesser M, Bengel FM, Freesmeyer M, Hertel A, Krohn T, Holzinger J, Brink I, Haberkorn U, Nyuyki F, van Assema DME, Geworski L, Hasenclever D, Jockel KH, Duhrsen U. Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the DeltaSUVmax Method. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2021;62(1):37-42.

Drescher R, Grober S, Seifert P, Freesmeyer M. Differentiation of residual splenic tissue from neuroendocrine tumor metastasis on PET/CT with heat-damaged, Ga-68-oxine-labeled red blood cells. Jpn J Clin Oncol. 2021;51(1):160-1.

Teichgraber U, Ingwersen M, Mentzel HJ, Aschenbach R, Neumann R, Franiel T, Herzog AB, Bottcher J, Pfeil A, Mensel B, Kuhnel C, Freesmeyer M, Fischer MR, Zottmann J. Impact of a Heutagogical, Multimedia-Based Teaching Concept to Promote Self-Determined, Cooperative Student Learning in Clinical Radiology. Rofo. 2021;193(6):701-11

Freesmeyer M, Grober S, Greiser J, Seifert P, Guhne F, Drescher R. PET/CT with [(68)Ga]gallium-oxine-labeled heat-denatured red blood cells for detection of dystopic splenic tissue. Eur J Nucl Med Mol Imaging. 2021;48(2):644-6.

Guhne F, Drescher R, Ndum F, Seifert P, Freesmeyer M. Complete Right-to-Left Shunt in Lung Perfusion Scintigraphy. Clinical nuclear medicine.  2021;46(3):e162-e4.

2020

Guhne F, Drescher R, Aschenbach R, Seifert P, Freesmeyer M. Dedicated Verification of an Accessory Parotid Gland via Minimal-Activity PSMA-PET/CT. Tomography. 2020;6(3):288-9.

Görges R, Bockisch A, Seifert P. Die „Standard"-Schilddrüsenszintigrafie – ist sie noch zeitgemäß? Der Nuklearmediziner. 2020;43(03):201-12.

Pfeil A, Franz M, Wolf G, Freesmeyer M. Refractory giant cell arteritis: the value of clinical symptoms and imaging. BMJ Case Rep. 2020;13(9).

Eisfeld H, Kircher S, Rosenwald A, Anagnostopoulos I, Werner M, Gassler N, Wolf G, Lehmkuhl L, Teichgraber U, Guhne F, Darr A, Freesmeyer M, Weschenfelder W, Hofmann G, Dalkilic R, Kalff R, Hochhaus A, Schrenk KG. Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL). Ann Hematol. 2020. [Epub ahead of print].

Schmitz C, Rekowski J, Muller SP, Farsijani N, Hertenstein B, Franzius C, von Verschuer U, La Rosee P, Freesmeyer M, Wilop S, Krohn T, Raghavachar A, Ganser A, Bengel FM, Prange-Krex G, Kroschinsky F, Kotzerke J, Giagounidis A, Duhrsen U, Huttmann A. Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapy. Cancer Med. 2020;9(22):8386-96.

Drescher R, Seifert P, Gühne F, Kühnel C, Aschenbach R, Freesmeyer M. Transarterial Radioembolization with Yttrium-90 Glass Microspheres: Distribution of Residual Activity and Flow Dynamics during Administration. Journal of Vascular and Interventional Radiology. 2020;31(9):1467-74.

Kuhnel C, Seifert P, Drescher R, Freesmeyer M. Reconstruction method to combine high temporal resolution with appropriate image quality in dynamic PET angiography. Eur J Nucl Med Mol Imaging. 2020;47(13):2954-5.

Freesmeyer M, Winkens T, Weissenrieder L, Kuhnel C, Guhne F, Schenke S, Drescher R, Seifert P. Fusion iENA Scholar Study: Sensor-Navigated I-124-PET/US Fusion Imaging versus Conventional Diagnostics for Retrospective Functional Assessment of Thyroid Nodules by Medical Students. Sensors (Basel). 2020;20(12).

Pfeil A, Franz M, Wolf G, Freesmeyer M. Refractory giant cell arteritis: the value of clinical symptoms and imaging. BMJ Case Rep. 2020;13(9).

Freesmeyer M, Weigel F, John U, Mentzel HJ, Guhne F. Real-Time DMSA-SPECT/US Fusion Imaging Revealing Nonscarring Loss of Function After Pyelonephritis. Clinical nuclear medicine. 2020;45(6):e274-e5.

Werner C, Lupp A, Mtuka-Pardon G, Kloos C, Wolf G, Aschenbach R, Biermann A, Freesmeyer M, Seifert P. Case report of a cystic parathyroidal adenoma with rapid growth induced by cinacalcet. BMC Endocrine Disorders. 2020;20(1):53.

Kuhnel C, Winkens T, Niksch T, Greiser J, Schrott S, Drescher R, Freesmeyer M. Design and practical evaluation of a shielded application system for intravenously administered radionuclide therapies. Nuklearmedizin. 2020;59(4):323-31.

Drescher R, Kuhnel C, Seifert P, Guhne F, Freesmeyer M. Renal and Intestinal Excretion of (90)Y and (166)Ho After Transarterial Radioembolization of Liver Tumors. AJR American journal of roentgenology. 2020:1-7.

Schmitz C, Rekowski J, Muller SP, Hertenstein B, Franzius C, Ganser A, Bengel FM, Kroschinsky F, Kotzerke J, La Rosee P, Freesmeyer M, Hoeffkes HG, Hertel A, Behringer D, Mesters R, Weckesser M, Mahlmann S, Haberkorn U, Martens U, Prange-Krex G, Brenner W, Giagounidis A, Moeller R, Runde V, Sandmann M, Hautzel H, Wilop S, Krohn T, Durk H, Heike M, Alashkar F, Brinkmann M, Trenn G, Wacker D, Kreisel-Bustgens C, Bernhard H, Heil G, Larisch R, Kurch L, Jockel KH, Hoelzer D, Klapper W, Boellaard R, Duhrsen U, Huttmann A. Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial. Hematol Oncol. 2020.

Seifert P, Freesmeyer M. Zum Beitrag „Empfehlung zum Calcitonin-Screening bei Struma nodosa". DMW - Deutsche Medizinische Wochenschrift. 2020;145(03):196-.

Kuhnel C, Seifert P, Mulik C, Winkens T, Freesmeyer M. 3D printing of fillable individual thyroid replicas based on nuclear medicine DICOM data used as phantoms for gamma probe calibration. Nuklearmedizin. 2020;59(1):12-9.

Guhne F, Weigel F, Kuhnel C, Seifert P, Freesmeyer M. DMSA-camSPECT/US fusion imaging of children's kidneys - Proof of feasibility. Nuklearmedizin. 2020;59(1):26-32.

Seifert P, Kloos E, Ritter K, Freesmeyer M. Calcitonin Screening - Consideration of Heterophilic Antibody Interference in a Case of Obscure Hypercalcitoninemia. Nuklearmedizin. 2020;59(1):35-7.

Seifert P, Gorges R, Zimny M, Kreissl MC, Schenke S. Interobserver agreement and efficacy of consensus reading in Kwak-, EU-, and ACR-thyroid imaging recording and data systems and ATA guidelines for the ultrasound risk stratification of thyroid nodules. Endocrine. 2020;67(1):143-54.

2019

Seifert P, Winkens T, Knichel L, Kuhnel C, Freesmeyer M. Stitching of 3D ultrasound datasets for the determination of large thyroid volumes - phantom study part II: mechanically-swept probes. Med Ultrason. 2019;21(4):389-98.

Winkens T, Seifert P, Hollenbach C, Kühnel C, Guhne F, Freesmeyer M. The FUSION iENA Study: Comparison of I-124-PET/US Fusion Imaging with Conventional Diagnostics for the Functional Assessment of Thyroid Nodules by Multiple Observers. Nuklearmedizin. 2019. [Epub ahead of print].

Greiser J, Weigand W, Freesmeyer M. Metal-Based Complexes as Pharmaceuticals for Molecular Imaging of the Liver. Pharmaceuticals2019, 12(3), 137

Gröber S, Matczak P, Domagała S, Weisheit T, Görls H, Düver A, Mlostoń G, Weigand W. Diferrocenyl Thioketone: Reactions with (Bisphosphane)Pt(0) Complexes—Electrochemical and Computational Studies. Materials 2019, 12, 2832.

Gühne F, Drescher R, Seifert P, Freesmeyer M. Minimal-activity PET/CT for efficacy control after SIRT (MAPECSI) - clinical implementation of a resource-saving, liver-focused protocol. Nuklearmedizin. 2019;58(5):363-70.

Freesmeyer M, Schwab M, Besteher B, Grober S, Waschke A, Drescher R. High-Resolution PET Cisternography With 64Cu-DOTA for CSF Leak Detection. Clin Nucl Med. 2019.

Seifert P, Winkens T, Kuhnel C, Guhne F, Freesmeyer M. I-124-PET/US Fusion Imaging in Comparison to Conventional Diagnostics and Tc-99m Pertechnetate SPECT/US Fusion Imaging for the Function Assessment of Thyroid Nodules. Ultrasound Med Biol. 2019;45(9):2298-308.

Freesmeyer M, Kuhnel C, Guhne F, Seifert P. Standard Needle Magnetization for Ultrasound Needle Guidance: First Clinical Experiences in Fine-Needle Aspiration Cytology of Thyroid Nodules. J Ultrasound Med. 2019;38(12):3311-9.

Drescher R, Seifert P, Aschenbach R, Freesmeyer M. Improvement of a Resin Transarterial Radioembolization Administration System. J Vasc Interv Radiol. 2019;30(6):907.

Freesmeyer M, Winkens T, Kuehnel C, Opfermann T, Seifert P. Technetium-99m SPECT/US Hybrid Imaging Compared with Conventional Diagnostic Thyroid Imaging with Scintigraphy and Ultrasound. Ultrasound in medicine & biology. 2019;45(5):1243-52.

Freesmeyer M, Goetze S, Elsner P, Gühne F. Recurrent metastatic occult melanoma - Long-term remission after detection of the primary tumor by FDG-PET/CT. Jpn J Clin Oncol. 2019;49(3):293-4.

Drescher R, Guhne F, Seifert P, Kuhnel C, Freesmeyer M. Ex Vivo Evaluation of Residual Activity and Infusion Dynamics in a Commercially Available Yttrium-90 Resin Microsphere Administration System. Journal of vascular and interventional radiology : JVIR. 2019.

Freesmeyer M, Drescher R, Roth J, Guhne F, Seifert P. Bilateral Pulmonary Thromboembolism Detected by PET Angiography in a Patient With Contraindications for Contrast Agent Imaging. Heart Lung Circ. 2019;28(4):e96-e8.

Freesmeyer M, Guhne F, Kuhnel C, Opfermann T, Winkens T, Werner A. Determination of effective half-life of (131)I in patients with differentiated thyroid carcinoma: comparison of cystatin C and creatinine-based estimation of renal function. Endocrine. 2019;63(3):554-62.

Schenke S, Seifert P, Zimny M, Winkens T, Binse I, Gorges R. Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2019;60(3):342-7.

Seifert P, Guhne F, Freesmeyer M. Hyperfunctioning Papillary Microcarcinoma Diagnosed by 124I PET/Ultrasound Fusion Imaging. Clinical nuclear medicine. 2019;44(5):404-5.

Guhne F, Drescher R, Seifert P, Busch M, Freesmeyer M. Inflammatory Activity of Tumoral Calcinosis in a Patient With Fever of Unknown Origin. Clinical nuclear medicine. 2019;44(4):e289-e90.

Seifert P, Guhne F, Theurer S, Freesmeyer M. Complete Remission After Single Radioiodine Therapy in Malignant Struma Ovarii With Bone and Lymph Node Metastases. Clin Nucl Med. 2019;44(1):42-4.

Huttmann A, Rekowski J, Muller SP, Hertenstein B, Franzius C, Mesters R, Weckesser M, Kroschinsky F, Kotzerke J, Ganser A, Bengel FM, La Rosee P, Freesmeyer M, Hoffkes HG, Hertel A, Behringer D, Prange-Krex G, Griesshammer M, Holzinger J, Wilop S, Krohn T, Raghavachar A, Maschmeyer G, Brink I, Schroers R, Gaska T, Bernhard H, Giagounidis A, Schutte J, Dienst A, Hautzel H, Naumann R, Klein A, Hahn D, Popperl G, Grube M, Marienhagen J, Schwarzer A, Kurch L, Hohler T, Steiniger H, Nuckel H, Sudhoff T, Romer W, Brinkmann M, Ose C, Alashkar F, Schmitz C, Durig J, Hoelzer D, Jockel KH, Klapper W, Duhrsen U. Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial. Ann Hematol. 2019;98(4):897-907.

2018

Kuehnel C, Winkens T, Freesmeyer M. Design, construction, and validation of a hybrid phantom for nuclear medicine and ultrasound fusion imaging. Appl Radiat Isot. 2018;145:120-5.

Freesmeyer M, Weigand W, Weisheit T. Examination of the complexation ability of different calixarene derivatives towards [223Ra]RaCl2 in a hospital radiopharmaceutical laboratory. Nuklearmedizin. 2018;57(6):242-6.

Freesmeyer M, Knichel L, Kuehnel C, Winkens T. Stitching of sensor-navigated 3D ultrasound datasets for the determination of large thyroid volumes a phantom study. Med Ultrason. 2018.

Seifert P, Guhne F, Theurer S, Freesmeyer M. Complete Remission After Single Radioiodine Therapy in Malignant Struma Ovarii With Bone and Lymph Node Metastases. Clin Nucl Med. 2018.

Freesmeyer M, Kunze A, Winkens T. 131I and 124I Accumulation in a Thymic Cyst: Reply. Clin Nucl Med. 2018.

Freesmeyer M, Winkens T, Kuehnel C, Opfermann T, Seifert P. 99mTc-Pertechnetate-SPECT/US Hybrid Imaging Enhances Diagnostic Certainty Compared With Conventional Thyroid Imaging With Scintigraphy and Ultrasound. Clin Nucl Med. 2018;43(10):747-8.

Freesmeyer M, Kuehnel C, Opfermann T, Niksch T, Wiegand S, Stolz R, Huonker R, Witte OW, Winkens T. The use of ostrich eggs for in ovo research - Making preclinical imaging research affordable and available. J Nucl Med. 2018.

Greiser J, Kuhnel C, Gorls H, Weigand W, Freesmeyer M. N,1,4-Tri(4-alkoxy-2-hydroxybenzyl)-DAZA: efficient one-pot synthesis and labelling with (68)Ga for PET liver imaging in ovo. Dalton Trans. 2018.

Duhrsen U, Muller S, Hertenstein B, Thomssen H, Kotzerke J, Mesters R, Berdel WE, Franzius C, Kroschinsky F, Weckesser M, Kofahl-Krause D, Bengel FM, Durig J, Matschke J, Schmitz C, Poppel T, Ose C, Brinkmann M, La Rosee P, Freesmeyer M, Hertel A, Hoffkes HG, Behringer D, Prange-Krex G, Wilop S, Krohn T, Holzinger J, Griesshammer M, Giagounidis A, Raghavachar A, Maschmeyer G, Brink I, Bernhard H, Haberkorn U, Gaska T, Kurch L, van Assema DME, Klapper W, Hoelzer D, Geworski L, Jockel KH, Scherag A, Bockisch A, Rekowski J, Huttmann A, Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial. J Clin Oncol. 2018;36(20):2024-34.

Kühnel C, Winkens T, Seifert P, Drescher R, Freesmeyer M. Radiation Exposure of the Investigator during Navigated Fusion of 124iodine Pet Imaging and Ultrasound. Radiat Prot Dosimetry. 2018.

Werner C, Lupp A, Drescher R, Freesmeyer M, Mireskandari M, Stoykow C, Bauschke A, Müller UA. Morphologically 'invisible' proinsulin - secreting adenoma detected by Ga-68 Exendin-4 (GLP-1 Receptor) positron emission tomography/CT. J Med Imaging Radiat Oncol. 2018.

2017

Goetze S, Freesmeyer M, Elsner P. Incidental detection of new-onset melanoma using PET-CT in a patient with stage III melanoma. J Dtsch Dermatol Ges. 2017;15(12):1229-31.

Seifert P, Drescher R, Pfeil A, Freesmeyer M. Large-vessel vasculitis in positron emission tomography and ultrasound fusion imaging. Rheumatology (Oxford). 2017;56(11):1992.

Drescher R, Seifert P, Aschenbach R, Freesmeyer M. Positron Emission Tomography/CT to Localize Radioactivity in a Radioembolization Delivery System. J Vasc Interv Radiol. 2017;28(11):1543.

Seifert P, Freesmeyer M. Preoperative diagnostics in differentiated thyroid carcinoma. Nuklearmedizin. 2017;56(6).

Freesmeyer M, Gühne F. Clarification of a suspicious thyroid nodule by use of camSPECT/US fusion imaging. Endocrine. 2017;58(1):199-200.

Drescher R, Marintschev I, Kaatz M, Kühnel C, Freesmeyer M. Giant cell tumor mimicking melanoma metastasis: radioguided surgery of a lesion detected on PET/CT. J Dtsch Dermatol Ges. 2017.

Freesmeyer M, Gabler AS, Kühnel C, Winkens T. Late 124I PET/CT Uptake Measurement-Assessment of Appropriate Examination Protocol in Benign Thyroid Diseases. Clin Nucl Med. 2017;42(7):514-9.

Gühne F, Kühnel C, Freesmeyer M. Comparing pre-therapeutic 124I and 131I uptake tests with intra-therapeutic 131I uptake in benign thyroid disorders. Endocrine. 2017;56(1):43-53.

Drescher R, Gühne F, Freesmeyer M. Early-Dynamic Positron Emission Tomography (PET)/Computed Tomography and PET Angiography for Endoleak Detection After Abdominal Endovascular Aneurysm Repair. J Endovasc Ther. 2017;24(3):421-4.

Bärwolf R, Zirnsak M, Freesmeyer M. Breath-hold and free-breathing F-18-FDG-PET/CT in malignant melanoma-detection of additional tumoral foci and effects on quantitative parameters. Medicine (Baltimore). 2017;96(2):e5882.

Pfeil A, Busch M, Oelzner P, Freesmeyer M, Renz DM, Drescher R, Hertel K, Wolf G. 42-year-old patient with urinary retention of unknown origin. Der Nephrologe. 2017;12(1):51-4.

Zirnsak M, Barwolf R, Freesmeyer M. Breath-hold [68Ga]DOTA-TOC PET/CT in neuroendocrine tumors: detection of additional lesions and effects on quantitative parameters. Q J Nucl Med Mol Imaging. 2017; [Epub ahead of print].

Franiel T, Kasel-Seibert M, Drescher R, Freesmeyer M. Primärstaging des Prostatakarzinoms. In: Attenberger U, Ritter M, Wenz F, editors. MR- und PET-Bildgebung der Prostata: Diagnostik und Therapieplanung. Berlin, Heidelberg: Springer Berlin Heidelberg; 2017. p. 111-37.

2016

Gühne F, Mothes H, Freesmeyer M. Allocation of parathyroid adenoma and suspicious thyroid nodule by real-time 99mTc-MIBI SPECT/US fusion imaging. Endocrine. 2016;54(2):560-1.

Sänger PW, Freesmeyer M. Early Dynamic 68Ga-DOTA-D-Phe1-Tyr3-Octreotide PET/CT in Patients With Hepatic Metastases of Neuroendocrine Tumors. Clinical nuclear medicine. 2016;41(6):447-53.

Günther A, Witte OW, Freesmeyer M, Drescher R. Clinical Presentation, Magnetic Resonance Angiography, Ultrasound Findings, and Stroke Patterns in Patients with Vertebral Artery Dissection. Eur Neurol. 2016;76(5-6):284-94.

Herrmann J, Böttcher J, Freesmeyer M, Täuscher D, Lesser T. Der pulmonale Rundherd. Ärzteblatt Thüringen. 2016(7-8):407-12.

Conrad F, Winkens T, Kaatz M, Goetze S, Freesmeyer M. Retrospective chart analysis of incidental findings detected by (18) F-fluorodeoxyglucose-PET/CT in patients with cutaneous malignant melanoma. J Dtsch Dermatol Ges. 2016;14(8):807-16.

Wilhelm T, Winkens T, Kunze A, Freesmeyer M. 131I and 124I Accumulation in a Thymic Cyst. Clinical nuclear medicine. 2016;41(12):972-4.

Bauschke A, Altendorf-Hofmann A, Freesmeyer M, Winkens T, Malessa C, Schierz JH, Teichgraeber U, Settmacher U. [Selective internal radioembolization in nonresectable hepatocellular carcinoma]. Der Chirurg. 2016;87(11):956-63.

Seifert P, Konig V, Hofmann GO, Freesmeyer M. Devitalized bone in a multi-fragment femoral shaft fracture detected by (18)F-NaF PET-CT. Nuklearmedizin. 2016;55(5):N52-3.

Greiser J, Niksch T, Weigand W, Freesmeyer M. Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue. J Vis Exp. 2016(114):e54334.

Burkle CP, Goetze S, Dieckmeyer C, Schliemann S, Freesmeyer M, Petersen I, Elsner P. Unclear periumbilical infiltration with induration. Journal of the German Society of Dermatology : JDDG. 2016;14(7):749-52.

Gühne F, Mothes H, Freesmeyer M. Allocation of parathyroid adenoma and suspicious thyroid nodule by real-time 99mTc-MIBI SPECT/US fusion imaging. Endocrine. 2016.

Werner C, Winkens T, Freesmeyer M. Splenic scintigraphy for further differentiation of unclear (68) Ga-DOTATOC-PET/CT findings: Strengths and limitations. Journal of medical imaging and radiation oncology. 2016;60(3):365-9.

Gabler AS, Kühnel C, Winkens T, Freesmeyer M. Assessment of minimum activity of 124Iodine in pre-therapeutic uptake measurement prior to radioiodine therapy of benign thyroid diseases. J Nucl Med. 2016;57(8):1201-6.

Pfeifer-Leeg M, Szabó G, Baranyai Z, Niksch T, Weigand W, Freesmeyer M. Synthesis and Characterization of GaIII, YIII, and LuIII Complexes with Etifenin and Analogues. Zeitschrift für anorganische und allgemeine Chemie. 2016;642(6):486-91.

Sänger PW, Freesmeyer M. Early Dynamic 68Ga-DOTA-D-Phe1-Tyr3-Octreotide PET/CT in Patients With Hepatic Metastases of Neuroendocrine Tumors. Clin Nucl Med. 2016;41(6):447-53.

Licht K, Kroegel C, Katenkamp K, Freesmeyer M. Anthracofibrosis Manifesting as False-Positive Iodine Accumulation in a Patient With Recent History of Thyroid Carcinoma. Clinical nuclear medicine. 2016;41(4):336-7.

Freesmeyer M, Winkens T, Opfermann T, Kühnel C. Radiation exposure of the investigator's hand during fusion imaging of the thyroid with 99mTcO4-free-hand SPECT and ultrasound. Radiation protection dosimetry. 2016;168(4):531-6.

Freesmeyer M, Winkens T. Ultrasound Fusion (SPECT/US). In: Herrmann K, Nieweg OE, Povoski SP, editors. Radioguided Surgery: Current Applications and Innovation Directions in Clinical Practice: Springer International Publishing; 2016. p. 471-80.

2015

Kapfhammer A, Winkens T, Lesser T, Reissig A, Steinert M, Freesmeyer M. Enhancing 18F-FDG-PET/CT analysis in lung cancer patients. Is CT-CT image fusion helpful in predicting pleural involvement? A pilot study. Nuklearmedizin. 2015;54(6):247-54.

Greiser J, Hagemann T, Niksch T, Traber P, Kupfer S, Gräfe S, Görls H, Weigand W, Freesmeyer M. Synthesis and Characterization of GaIII, InIII and LuIII Complexes of a Set of dtpa Bis-Amide Ligands. European Journal of Inorganic Chemistry (2015), 2015(24), 4125-4137.

Jetschke K, Viehweger H, Freesmeyer M, Warnke JP, Mawrin C. Primary pineal malignant melanoma with B-Raf V600E mutation: a case report and brief review of the literature. Acta neurochirurgica. 2015;157(7):1267-70.

Freesmeyer M, Drescher R. F-18 Choline PET angiography of the pelvic arteries: evaluation of image quality and comparison with contrast-enhanced CT. Clinical imaging. 2014;in press(0). Epub Oct 2104. doi:10.1016/j.clinimag.2014.08.007

Drescher R, Freesmeyer M. F-18 fluorodeoxyglucose PET angiography of the abdominal arteries: evaluation of image quality and comparison with contrast-enhanced CT. Ann Nucl Med. 2015;29(2):198-205.

Freesmeyer M, Winkens T, Darr A. Diagnosis of Small Papillary Thyroid Cancer via Sensor-navigated Iodine PET/Ultrasound (I-PET/US) Fusion. J Clin Endocrinol Metab. 2015;100(1):13-4.

Sorg S, Pachmann K, Brede-Hekimian K, Freesmeyer M, Winkens T. Determining tissue origin of circulating epithelial cells (CEC) in patients with differentiated thyroid cancer by real-time PCR using thyroid mRNA probes. Cancer Lett. 2015;356(2 Pt B):491-5.

Freesmeyer M, Kühnel C, Westphal JG. Time Efficient Low-activity 124 I-PET Volumetry in Benign Thyroid Disorders by Automatic Isocontour Procedures: Mathematic Adjustment Using Manual Contoured Measurements in Low-dose CT. Ann Nucl Med. 2015;29(1):8-14.

Freesmeyer M, Elsner P, Goetze S, Kaatz M, Winkens T. Positron emission tomography/ultrasound fusion technique in patients with malignant melanoma. J Med Imaging Radiat Oncol. 2015;59(3):320-5.

Freesmeyer M, Opfermann T. Diagnosis of de quervain's subacute thyroiditis via sensor-navigated (124)Iodine PET/ultrasound ( (124)I-PET/US) fusion. Endocrine 49(1): 293-295.

Freesmeyer M, Opfermann T, Winkens T. Response to the Letter of Prof. Otte and Prof. Hoppe to Hybrid Integration of Real-time US and Freehand SPECT: Proof of Concept in Patients with Thyroid Diseases. RADIOLOGY 274(1): 305.

Meiser M, Winkens T, Freesmeyer M. Radio-Guided Surgery and Postoperative PET/CT Scan of a Surgical Specimen of an Intraosseous Meningioma in a Patient With Neuroendocrine Tumor of the Pancreas. Clin Nucl Med 40(5): 419-420.

2014

Czaplewska JA, Theil F, Altuntas E, Niksch T, Freesmeyer M, Happ B, Pretzel D, Schäfer H, Obata M, Yano S, Schubert, US, Gottschaldt M. Glycoconjugated Rhenium(I) and 99m-Technetium(I) Carbonyl Complexes from Pyridyltriazole Ligands Obtained by “Click Chemistry”. Eur J Inorg Chem. 2014: 62906297

Irmler IM, Gebhardt P, Hoffmann B, Opfermann T, Figge MT, Saluz HP, Kamradt T. 18F-Fluoride positron emission tomography/computed tomography for non-invasive in vivo quantification of pathophysiological bone metabolism in experimental murine arthritis. Arthritis research & therapy. 2014 Jul 22;16(4):R155.

Bärwolf R, Zirnsak M, Freesmeyer M. Detection of a Liver Metastasis by Breath-hold FDG-PET/CT Not Visible on Standard PET/CT. Jpn J Clin Oncol 2014;44(8):775

Drescher R, Freesmeyer M. PET/US fusion as a problem-solving tool in oncology imaging: differentiation of hernia repair mesh plugs from malignancy suspected on PET/CT. Clin Nucl Med. 2014;39(1):e75-7.

Freesmeyer M. Hybridbildgebung: Nuklearmedizin und Ultraschall aus einer Hand. best practice onkologie. 2014;9(1):48. 

Freesmeyer M, Dralle H, Winkens T. Diagnosis of small medullary thyroid carcinoma via PET/ultrasound (US) fusion. Jpn J Clin Oncol. 2014;44(3):300-1.

Freesmeyer M, Drescher R, Winkens T. Unexpected diagnosis of peripheral schwannoma on 18F-fluoroethylcholine PET/CT for localization of prostate cancer recurrence and biopsy under real-time PET/ultrasound fusion guidance. Clin Nucl Med. 2014;39(4):385-6.

Freesmeyer M, Opfermann T, Winkens T. Hybrid integration of real-time US and freehand SPECT: proof of concept in patients with thyroid diseases. Radiology. 2014;271(3):856-61. 

Freesmeyer M, Schleussner E, Winkens T. Diagnosis of Struma Ovarii in a Patient with Papillary Thyroid Carcinoma - Verification via 124I-PET/US Fusion. Ultraschall Med. 2014;35(4):368-70.

Freesmeyer M, Stecker FF, Schierz JH, Hofmann GO, Winkens T. First experience with early dynamic (18)F-NaF-PET/CT in patients with chronic osteomyelitis. Ann Nucl Med. 2014;28(4):314-21.

Freesmeyer M, Wiegand S, Schierz JH, Winkens T, Licht K. Multimodal evaluation of 2-d and 3-d ultrasound, computed tomography and magnetic resonance imaging in measurements of the thyroid volume using universally applicable cross-sectional imaging software: a phantom study. Ultrasound Med Biol. 2014;40(7):1453-62.

Freesmeyer M, Winkens T, Drescher R. Avoidance of false-positive findings on (1)(8)F-FDG-PET/CT using PET/ultrasound fusion: displaced laryngeal silicone implant versus recurrent cancer. Jpn J Clin Oncol. 2014;44(4):397.

Freesmeyer M, Winkens T, Kühnel C. Real-time handheld emission spot allocator (rthESA) for simultaneous fusion imaging with ultrasound. Nuklearmedizin. 2014;53(6):265-71.

Freesmeyer M, Winkens T, Opfermann T, Elsner P, Runnebaum I, Darr A. Real-time ultrasound and freehand-SPECT. Experiences with sentinel lymph node mapping. Nuklearmedizin. 2014;53(6):259-64.

Freesmeyer M, Winkens T, Schierz JH. Contrast between hypervascularized liver lesions and hepatic parenchyma: early dynamic PET versus contrast-enhanced CT. Ann Nucl Med. 2014;28(7):664-8.

Freesmeyer M, Zanow J, Ludewig S, Drescher R. Multimodal imaging of aortoiliac occlusive disease with three-dimensional postprocessing of PET angiography and CT. Clin Imaging. 2014;38(6):877-9.

Kunze A, Drescher R, Kaiser K, Freesmeyer M, Witte OW, Axer H. Serial FDG PET/CT in Autoimmune Encephalitis With Faciobrachial Dystonic Seizures. Clin Nucl Med. 2014;39(10):e436-8.

Licht K, Darr A, Opfermann T, Winkens T, Freesmeyer M. 3D ultrasonography is as accurate as low-dose CT in thyroid volumetry. Nuklearmedizin. 2014;53(3):99-104.

Sanger P, Schierz JH, Marlowe RJ, Freesmeyer M. Detectability of hypervascularity in early dynamic PET depends on tracer kinetics: (18) F-FDG versus (68) Ga-DOTATOC in hepatic NET metastasis. Liver Int. 2014;34(1):161.

Schierz JH, Winkens T, Freesmeyer M. Early dynamic PET/CT shows open portocaval shunt in a patient with liver cirrhosis. Liver Int. 2014;34(2):322.

Stecker FF, Schierz JH, Opfermann T, Driesch D, Hofmann GO, Winkens T, Freesmeyer M. Early dynamic 18F-FDG PET/CT to diagnose chronic osteomyelitis following lower extremity fractures. A pilot study. Nuklearmedizin. 2014;53(3):117-22. 

Tauhardt E, Reissig A, Winkens T, Freesmeyer M. Early detection of disease progression after palliative chemotherapy in NSCLC patients by 18F-FDG-PET. Nuklearmedizin. 2014;53(5):197-204.

Westphal JG, Winkens T, Kühnel C, Freesmeyer M. Low-Activity (124)I-PET/Low-Dose CT Versus (131)I Probe Measurements in Pretherapy Assessment of Radioiodine Uptake in Benign Thyroid Diseases. J Clin Endocrinol Metab. 2014;99(6):2138-45.

Winkens T, Nietzsche S, Gottschaldt M, Freesmeyer M. Nonspecific iodine accumulation in surgical suture material mimicking follicular thyroid cancer bone metastasis in (131)I scintigraphy. Clin Nucl Med. 2014;39(2):209-10.

Winkens T, Pachmann K, Freesmeyer M. The Influence of Radioiodine Therapy on the Number of Circulating Epithelial Cells (CEC) in Patients with Differentiated Thyroid Carcinoma - a Pilot Study. Exp Clin Endocrinol Diabetes. 2014;122(4):246-53.

2013

Darr AM, Opfermann T, Niksch T, Driesch D, Marlowe RJ, Freesmeyer M. Low-activity 124I-PET/low-dose CT versus 99mTc-pertechnetate planar scintigraphy or 99mTc-pertechnetate single-photon emission computed tomography of the thyroid: a pilot comparison. Clin Nucl Med. 2013;38(10):770-7.

Drescher R, Freesmeyer M. PET angiography: Application of early dynamic PET/CT to the evaluation of arteries. AJR Am J Roentgenol. 2013;201(4):908-11.

Drescher R, Freesmeyer M, Kraußlach H. Strukturierte Karrieremodelle für Fachärzte: Standortvorteil zur Personalbindung. Dtsch Arztebl International. 2013;110(20):A 9847.

Drescher R, Muller A, Lesser T, Freesmeyer M. PET/ultrasound fusion for differentiation of Vox implant silicone particles from recurrent cancer. Nuklearmedizin. 2013;52(3):N29-30.

Freesmeyer M. Regarding Dynamic Bone Imaging with 99mTc-Labeled Diphosphonates and 18F-NaF: Mechanisms and Applications. J Nucl Med. 2013;54(12):2190.

Gühne F, Winkens T, Mothes H, Freesmeyer M. Differential diagnosis of thyroid nodules via real-time PET/ultrasound (US) fusion in a case of co-existing medullary thyroid cancer and adenoma. J Clin Endocrinol Metab. 2013;98(11):4250-1.

Rupprecht S, Walther B, Gudziol H, Steenbeck J, Freesmeyer M, Witte OW, Günther A, Schwab M. Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder. Sleep Med. 2013;14(11):1064-70.

Schierz JH, Opfermann T, Steenbeck J, Lopatta E, Settmacher U, Stallmach A, Marlowe RJ, Freesmeyer M. Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions. J Nucl Med. 2013;54(6):848-54.

Schule S, Altendorf-Hofmann A, Utess F, Rauchfuss F, Freesmeyer M, Knosel T, Dittmar Y, Settmacher U. Liver transplantation for hilar cholangiocarcinoma--a single-centre experience. Langenbecks Arch Surg. 2013;398(1):71-7.

Vogel K, Opfermann T, Wiegand S, Biermann J, Busch M, Winkens T, Freesmeyer M. Relationship between estimated glomerular filtration rate and biological half-life of 131I. Retrospective analysis in patients with differentiated thyroid carcinoma. Nuklearmedizin. 2013;52(5):164-9. doi:10.3413/Nukmed-0575-13-03.

Winkens T, Pachmann K, Freesmeyer M. Circulating epithelial cells in patients with thyroid carcinoma. Can they be identified in the blood? Nuklearmedizin. 2013;52(1):7-13. doi:10.3413/Nukmed-0524-12-08.

2012

Freesmeyer M, Darr A, Schierz JH, Schleussner E, Wiegand S, Opfermann T. 3D ultrasound DICOM data of the thyroid gland. First experiences in exporting, archiving, second reading and 3D processing. Nuklearmedizin. 2012;51(3):73-8. doi:10.3413/Nukmed-0471-12-01

Freesmeyer M, Lopatta E, Schierz JH, Steenbeck J, Opfermann T, Settmacher U. Early dynamic PET imaging shows hypervascularization as exact as contrast-enhanced MR. Nuklearmedizin. 2012;51(1):N10-1.

Gunther A, Brodoehl S, Witte OW, Freesmeyer M, Dalmau JO, Redecker C. Atypical posthypoxic MRI changes in hypermetabolic regions in anti-NMDA-receptor encephalitis. Neurology. 2012;79(7):720-1.

Knosel T, Chen Y, Altendorf-Hofmann A, Danielczok C, Freesmeyer M, Settmacher U et al. High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event. J Cancer Res Clin Oncol. 2012;138(3):397-403.

Kotzerke J, Luster M, Freesmeyer M. [Give me a fixed point in space, and I will lift the world upside down]. Nuklearmedizin. 2012;51(3):65-6.

Wurbach L, Heidrich A, Opfermann T, Gebhardt P, Saluz HP. Insights into bone metabolism of avian embryos in ovo via 3D and 4D 18F-fluoride positron emission tomography. Mol Imaging Biol. 2012;14(6):688-98.

2011

Freesmeyer M. A severe haematologic adverse reaction after high dosage radioiodine therapy following blood stem cell mobilization with growth factors. Nuklearmedizin. 2011;50(4):N34-6.

Pfeil A, Busch M, Böttcher J, Hansch A, Freesmeyer M, Wolf G. Nichtinvasive bildgebende Verfahren - Technische Innovationen und Wertigkeit in der Nephrologie. Dialyse aktuell. 2011;15(09):512-22.

Schnetzke U, Bossert T, Scholl S, Freesmeyer M, Hochhaus A, La Rosee P. Drug-induced lymphadenopathy with eosinophilia and renal failure mimicking lymphoma disease: dramatic onset of DRESS syndrome associated with antibiotic treatment. Ann Hematol. 2011;90(11):1353-5.

2010

Fischle EM, Pfeil A, Odparlik A, Neumann T, Zanow J, Hansch A, Oelzner P, Freesmeyer M, Wolf G. Darstellung einer infizierten Gefaßprothese der Arteria iliaca externa mittels 18F-Fluorodeoxyglukose-Ganzkörper-PET-Computertomografie bei einem Patienten nach Nierentransplantation. Nieren- und Hochdruckkrankheiten. 2010;39(de).

Hellwig D, Krause BJ, Schirrmeister H, Freesmeyer M. [Bone scanning with sodium 18F-fluoride PET and PET/CT. German guideline Version 1.0.]. Nuklearmedizin. 2010;49(5):195-201.

Kinne RW, Emmrich F, Freesmeyer M. Clinical impact of radiolabeled anti-CD4 antibodies in the diagnosis of rheumatoid arthritis. Q J Nucl Med Mol Imaging. 2010;54(6):629-38.

Pfeil A, Neumann T, Romhild U, Fischle EM, Odparlik A, Steiner G, Mandecka A, Oelzner P, Freesmeyer M, Wolf G. Images in Cardiovascular Medicine. Inflammatory obstruction of the ureter caused by infrarenal aortitis. Circulation. 2010;121(25):e453-4.

Schummer C, Sakr Y, Steenbeck J, Gugel M, Reinhart K, Schummer W. Risk of extravasation after power injection of contrast media via the proximal port of multilumen central venous catheters: case report and review of the literature. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2010;182(1):14-9.

2009

Axer H, Huge S, Wilhelm C, Axer M, Kunze A, Reichenbach JR, Freesmeyer M, Kohlhase J, Sauer H, Bar KJ. [Hereditary Alzheimer's disease with amyloid angiopathy caused by amyloid precursor protein locus]. Der Nervenarzt. 2009;80(1):62-3, 5-7.

Freesmeyer M, Schulz S, Knosel T, Settmacher U. Imaging of somatostatin receptor subtype 2 in advanced hepatocellular carcinoma by 68Ga-DOTATOC PET. Nuklearmedizin. 2009;48(3):N17-8.

Freesmeyer M, Wurst C, Uberrueck T, Scholz T, Knosel T, Schulz S, Settmacher U. Intraoperative identification of a neuroendocrine tumour diagnosed by 68Ga-DOTATOC PET but undetectable by surgical palpation or conventional imaging. Nuklearmedizin. 2009;48(5):N50-1.

Kornberg A, Freesmeyer M, Barthel E, Jandt K, Katenkamp K, Steenbeck J, Sappler A, Habrecht O, Gottschild D, Settmacher U. 18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients. Am J Transplant. 2009;9(3):592-600.

Neumann T, Oelzner P, Freesmeyer M, Hansch A, Opfermann T, Hein G, Wolf G. Images in cardiovascular medicine. Diagnosis of large-vessel vasculitis by [18F] fluorodeoxyglucose-positron emission tomography. Circulation. 2009;119(2):338-9.

2008

Wirsing M, Schummer C, Neumann R, Steenbeck J, Schmidt P, Schummer W. Is traditional reading of the bedside chest radiograph appropriate to detect intraatrial central venous catheter position? Chest. 2008;134(3):527-33.